Browse by Audience
Skip to content
Papers of the Week
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study.
Abstract
Transition from originator biological medicines to their biosimilar equivalents is now part of routine clinical practice, but there is little understanding of patient experiences, which influence adherence and overall satisfaction with care. Understanding this will help ensure future switches adequately address patients' concerns and expectations leading to better outcomes for all stakeholders.